Cargando…
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), the second leading cause of cancer deaths worldwide, is difficult to treat and highly lethal. Since HCC is predominantly diagnosed in patients with cirrhosis, treatment planning must consider both the severity of liver disease and tumor burden. To minimize the impact...
Autores principales: | Faltermeier, Claire, Busuttil, Ronald W., Zarrinpar, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548262/ https://www.ncbi.nlm.nih.gov/pubmed/28943622 http://dx.doi.org/10.3390/diseases3040221 |
Ejemplares similares
-
Current Trends in Surgical Management of Hepatocellular Carcinoma
por: Angeli-Pahim, Isabella, et al.
Publicado: (2023) -
De novo Hepatocellular Carcinoma after Liver Transplantation
por: Saab, Sammy, et al.
Publicado: (2015) -
Perspectives of Molecular Therapy-Targeted Mitochondrial Fission in Hepatocellular Carcinoma
por: Zhang, Hanwen, et al.
Publicado: (2020) -
Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
por: Tsirulnikov, Kirill, et al.
Publicado: (2018) -
Targeted Therapy in Hepatocellular Carcinoma
por: Chua, Clarinda W. L., et al.
Publicado: (2011)